Exploring the dual role of TP53 mutations in bladder cancer prognosis and treatment response, from basic biology to clinical implications.
Discover how the MDM2 C1797G polymorphism affects bladder cancer risk in Chinese populations through enhanced transcription factor binding and increased MDM2 expression.